AssetMark’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
AssetMark's TAK Position: Q3 2026 in Review
AssetMark reduced its Takeda Pharmaceutical (TAK) stake by 8.1% in Q3 2026, selling an estimated $453K and leaving 289,107 shares worth $5.26M. The position accounts for 0.01% of the portfolio, ranked #731.
AssetMark first reported a position in TAK in Q1 2019 and has held it in 29 quarters since. 332 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- AssetMark held 289,107 shares of Takeda Pharmaceutical worth $5.26M as of Q3 2026.
- AssetMark sold 25,580 Takeda Pharmaceutical shares in Q3 2026, an estimated $453K.
- Takeda Pharmaceutical made up 0.01% of AssetMark's portfolio in Q3 2026, its #731 holding.
- AssetMark first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 29 quarters since.
- 332 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.